Central Nervous System Anxiety

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Anxiety Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Anxiety Projects
--Addex Pharmaceuticals SA
--Abiogen Pharma S.p.A.
--AstraZeneca Plc
--Asahi Kasei Corporation
--Bristol-Myers Squibb Company
--Avera Pharmaceuticals, Inc.
--Fabre-Kramer Pharmaceuticals, Inc.
--Eli Lilly & Co
--GlaxoSmithKline plc
--Forest Laboratories Inc
--Neurocrine Biosciences Inc
--Mitsubishi Tanabe Pharma Corporation
--Pfizer Inc
--Ono Pharmaceutical Co., Ltd.
--Sanofi-Aventis
--Pherin Pharmaceuticals, Inc.
--SK Bio-Pharmaceuticals
--Sepracor Inc
--Tikvah Therapeutics, Inc.
--Synovics Pharmaceuticals Inc

--Top Companies in early stage Anxiety Projects
--Ariston Pharmaceuticals, Inc.
--Addex Pharmaceuticals SA
--Bionomics Limited
--AstraZeneca Plc
--Fabre-Kramer Pharmaceuticals, Inc.
--Eli Lilly & Co
--GlaxoSmithKline plc
--Faust Pharmaceuticals
--Krenitsky Pharmaceuticals Inc.
--Johnson & Johnson
--NeuroSearch A/S
--Neurogen Corporation
--Pharmos Corporation
--Novartis AG
--Roche Holdings Ltd
--Pherin Pharmaceuticals, Inc.
--Sanofi-Aventis
--Rottapharm SpA
--Xytis, Inc.
--Taisho Pharmaceutical Co., Ltd.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--Post Marketing Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View